Literature DB >> 9383728

Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data.

J F Krzyzaniak1, F A Alvarez Núñez, D M Raymond, S H Yalkowsky.   

Abstract

The dynamic in vitro method developed by the authors and other available in vitro methods were used to determine the degree of hemolysis induced by several cosolvent vehicles that have previously been evaluated in vivo. The in vitro data generated for each of these vehicles was compared with the in vivo hemolysis data to assess the ability of the method to estimate in vivo hemolysis. The results show that the in vitro data generated by the dynamic method are in agreement with the in vivo data for each vehicle. Therefore, the potential for formulations to induce intravascular hemolysis after injection can be determined by this dynamic in vitro method. With this information, hemolytically safe formulations can more easily be prepared.

Entities:  

Mesh:

Year:  1997        PMID: 9383728     DOI: 10.1021/js970184o

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Effects of various arterial infusion solutions on red blood cells in the newborn.

Authors:  J K Jackson; D P Derleth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

2.  Composition optimization and stability testing of a parenteral antifungal solution based on a ternary solvent system.

Authors:  Kristóf Kovács; István Antal; György Stampf; Imre Klebovich; Krisztina Ludányi
Journal:  AAPS PharmSciTech       Date:  2010-02-24       Impact factor: 3.246

3.  Method for analysis of nanoparticle hemolytic properties in vitro.

Authors:  Marina A Dobrovolskaia; Jeffrey D Clogston; Barry W Neun; Jennifer B Hall; Anil K Patri; Scott E McNeil
Journal:  Nano Lett       Date:  2008-07-08       Impact factor: 11.189

4.  Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis.

Authors:  Maheshkumar P Soni; Nilakash Shelkar; Rajiv V Gaikwad; Geeta R Vanage; Abdul Samad; Padma V Devarajan
Journal:  J Pharm Bioallied Sci       Date:  2014-01

5.  Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer Therapy.

Authors:  Jyothi U Menon; Aneetta Kuriakose; Roshni Iyer; Elizabeth Hernandez; Leah Gandee; Shanrong Zhang; Masaya Takahashi; Zhang Zhang; Debabrata Saha; Kytai T Nguyen
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

6.  Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers.

Authors:  Satya Siva Kishan Yalamarty; Nina Filipczak; Xiang Li; Tanvi Vinod Pathrikar; Colin Cotter; Vladimir P Torchilin
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525

7.  Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems.

Authors:  Neill J Liptrott; Marco Giardiello; Tom O McDonald; Steve P Rannard; Andrew Owen
Journal:  J Nanobiotechnology       Date:  2018-03-15       Impact factor: 10.435

8.  Chemoenzymatic Synthesis of the New 3-((2,3-Diacetoxypropanoyl)oxy)propane-1,2-diyl Diacetate Using Immobilized Lipase B from Candida antarctica and Pyridinium Chlorochromate as an Oxidizing Agent.

Authors:  Esteban Plata; Mónica Ruiz; Jennifer Ruiz; Claudia Ortiz; John J Castillo; Roberto Fernández-Lafuente
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

9.  Highlighting the Importance of Water Alkalinity Using Phosphate Buffer Diluted With Deionized, Double Distilled and Tap Water, in Lowering Oxidation Effects on Human Hemoglobin Ozonated at High Ozone Concentrations in vitro.

Authors:  Fouad Mehraban; Saeed Rayati; Vahid Mirzaaghaei; Arefeh Seyedarabi
Journal:  Front Mol Biosci       Date:  2020-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.